Honoring Pride Month
ACRP honors Pride Month to recognize the importance of representation of the LGBTQIA+ community in clinical trials.
Research should welcome and be inclusive of people who are of all genders and sexual orientations.
“Clinical research must be a mirror reflecting the rich tapestry of humanity, and LGBTQIA+ inclusion is an essential thread in that fabric. Only by amplifying these voices can we weave a comprehensive narrative of health and well-being that leaves no one behind.”
Liam Paschall (he/him)
Former Associate Director, Learning and Development at Parexel;
LinkedIn Top 10 LGBTQIA+ Voice
CURATED RESOURCES
—
ACRP has curated recent educational programs and research perspectives on the importance of representation of the LGBTQIA+ community in a variety of clinical settings. Please share this information with your peers in the clinical research community to increase awareness and understanding.
In this live webinar, expert panelists will discuss how sponsors can smooth the LGBTQIA+ patient journey for clinical trials, starting with gender-neutral protocols, how to make trial communication more inclusive, the FDA’s draft guidance on diversity plans and data collection, and the roles that sites/investigators can play.
July 10, 2024
12:00 – 1:00 PM ET
To help recognize Pride Month, the ACRP Blog shares an early look at the lead peer-reviewed Clinical Researcher article on “Improving Cardiovascular Research for Transgender and Gender Diverse Populations” from a trio of WCG IRB expert contributors to the June 2024 issue.
The article joins several other pieces on patient centricity.
Transgender and gender diverse (TGGD) individuals face an increased risk of cardiovascular disease (CVD). There is an unmet need to identify the root causes of CVD health disparities in this population. More research and evidence-based strategies are needed to increase TGGD representation in CVD clinical studies.
Clinical Researcher – June 2024 (Volume 38, Issue 3)
How to Make Clinical Trials More Diverse and Inclusive
Clinical Researcher – April 2022 (Volume 36, Issue 2)
Clinical Trials Must Evolve to Better Serve the LGBTQ+ Community
ACRP Blog – June 28, 2022
From the Outside In: An Overview of Four Decades of Progress on HIV/AIDS
Clinical Researcher – October 2023 (Volume 37, Issue 5)
“The LGBTQIA+ community is significantly underrepresented in clinical trials. A comprehensive analysis by Parexel colleagues, which included over 116,000 published articles detailing clinical trial outcomes from July 2018 to February 2022, revealed that only 78 of those articles reported participation from transgender individuals. It is imperative to champion the inclusion of all diverse groups in clinical research and to acknowledge the multifaceted identities of individuals.”
Jamie Langley, RN MSN (she/her/hers)
Executive Director, Global Head of Parexel Academy
Parexel International
“Inclusive clinical research is crucial because it brings in diverse perspectives and experiences, which lead to better healthcare solutions for everyone. Pride Month is a vital reminder of the need for visibility and equity for the LGBTQIA+ community, both within the workforce and among research participants.”
Chad Michael Hunter, PhD, PMP, ACRP-PM
Local Delivery Lead, US, GSK;
Vice President, ACRP RTP Chapter
Pride Month is an annual celebration of the contributions made by the LGBTQ+ community to history, society, and cultures worldwide. In most places, Pride is celebrated throughout the month of June each year in commemoration of its roots in the Stonewall Riots of June 1969. Read about the origins of Pride Month. The White House issued a Proclamation on Lesbian, Gay, Bisexual, Transgender, Queer, and Intersex Pride Month on May 31, 2024.